Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1–42) compared to Aβ(1–40)
Abstract Intraneuronal accumulation of amyloid-β (Aβ) peptides represent an early pathological feature in Alzheimer’s disease. We have therefore utilized flow cytometry and confocal microscopy in combination with endocytosis inhibition to explore the internalisation efficiency and uptake mechanisms...
Guardado en:
Autores principales: | Emelie Wesén, Gavin D. M. Jeffries, Maria Matson Dzebo, Elin K. Esbjörner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e34dbcaafc034c5c8abcd94164b12032 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fluorescence correlation spectroscopy reveals a cooperative unfolding of monomeric amyloid-β 42 with a low Gibbs free energy
por: Mario Schneider, et al.
Publicado: (2017) -
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021) -
Β-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons.
por: Linn Wicklund, et al.
Publicado: (2010) -
The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide implicated in Alzheimer disease progression
por: Maa O. Quartey, et al.
Publicado: (2021) -
Amyloid-β peptide binds to cytochrome C oxidase subunit 1.
por: Luis Fernando Hernandez-Zimbron, et al.
Publicado: (2012)